Anterior Chamber Paracentesis Might Prevent Sustained Intraocular Pressure Elevation after Intravitreal Injections of Ranibizumab for Age-Related Macular Degeneration

Publisher： Karger

E-ISSN： 1423-0259|52|4|234-238

ISSN： 0030-3747

Source： Ophthalmic Research, Vol.52, Iss.4, 2014-11, pp. : 234-238

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Case of Sustained Intraocular Pressure Elevation after Multiple Intravitreal Injection of Ranibizumab and Aflibercept for Neovascular Age-Related Macular Degeneration

By  

Case Reports in Ophthalmology, Vol. 7, Iss. 1, 2016-04 ,pp. : 230-236

Karger

Access to resources Recommend Favorite

Is There Any Difference between Ranibizumab and Aflibercept Injections in Terms of Inflammation Measured with Anterior Chamber Flare Levels in Age-Related Macular Degeneration Patients: A Comparative Study

By  

Ophthalmic Research, Vol. 56, Iss. 1, 2016-03 ,pp. : 35-40

Karger

Access to resources Recommend Favorite

Retinal Nerve Fiber Loss in Anti-VEGF Therapy for Age-Related Macular Degeneration Can Be Decreased by Anterior Chamber Paracentesis

By  

Ophthalmologica, Vol. 237, Iss. 2, 2017-03 ,pp. : 111-118

Karger

Access to resources Recommend Favorite

Intravitreal Ranibizumab for Predominantly Hemorrhagic Choroidal Neovascularization in Age-Related Macular Degeneration

By  

Ophthalmologica, Vol. 233, Iss. 2, 2015-01 ,pp. : 74-81

Karger

Access to resources Recommend Favorite

Long-Term Intraocular Pressure Changes in Patients with Neovascular Age-Related Macular Degeneration Treated with Ranibizumab

By  

Ophthalmologica, Vol. 229, Iss. 3, 2013-03 ,pp. : 168-172

Karger

Access to resources Recommend Favorite